Viatris (VTRS) Times Interest Earned (2019 - 2026)
Viatris' (VTRS) quarterly Times Interest Earned came in at -$0.07 in Q1 2026, up 97.17% year-on-year from -$0.03 in Q1 2025, and up 95.9% quarter-over-quarter from -$1.61 in Q4 2025.
Viatris (VTRS) Times Interest Earned (2019 - 2026) Analysis & Trends
Viatris' Times Interest Earned history runs 8 years deep, the most recent figure standing at -$0.07 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 97.17% year-over-year to -$0.07 in Q1 2026; TTM through Mar 2026 was $0.12, a 104.63% increase from a year earlier, with the FY2025 full-year figure at -$1.85, down 22684.35% from the prior year.
- Times Interest Earned grew to -$0.07 in Q1 2026 per VTRS's latest filing, from -$1.61 in the prior quarter.
- Across five years, Times Interest Earned topped out at $3.19 in Q3 2023 and bottomed at -$3.23 in Q4 2023.
- The 5-year median for Times Interest Earned is $0.19 (2025), against an average of -$0.09.
- Across the five-year window, Times Interest Earned jumped 1334.9% in 2022 and sank 2128.02% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$1.37 in 2022, then plunged by 135.72% to -$3.23 in 2023, then jumped by 53.63% to -$1.5 in 2024, then declined by 7.71% to -$1.61 in 2025, then soared by 95.9% to -$0.07 in 2026.
- Per Business Quant, the three latest VTRS Times Interest Earned figures stand at -$0.07 (Q1 2026), -$1.61 (Q4 2025), and $1.49 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.07 |
| Dec 31, 2025 | -1.61 |
| Sep 30, 2025 | 1.49 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | -2.34 |
| Dec 31, 2024 | -1.50 |
| Sep 30, 2024 | 1.55 |
| Jun 30, 2024 | -1.65 |
| Mar 31, 2024 | 0.12 |
| Dec 31, 2023 | -3.23 |
| Sep 30, 2023 | 3.19 |
| Jun 30, 2023 | 2.57 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | -1.37 |
| Sep 30, 2022 | 0.27 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.33 |
| Dec 31, 2021 | -0.52 |
| Sep 30, 2021 | 0.16 |
| Jun 30, 2021 | -0.02 |